Neurologic uses of botulinum neurotoxin type A

John P Ney, Kevin R JosephMadigan Army Medical Center, Neurology Service, Tacoma, WA, USAAbstract: This article reviews the current and most neurologic uses of botulinum neurotoxin type A (BoNT-A), beginning with relevant historical data, neurochemical mechanism at the neuromuscular junction. Curren...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: John P Ney, Kevin R Joseph
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2007
Materias:
Acceso en línea:https://doaj.org/article/bd19972e45e94d59811dee16cc73c4b8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bd19972e45e94d59811dee16cc73c4b8
record_format dspace
spelling oai:doaj.org-article:bd19972e45e94d59811dee16cc73c4b82021-12-02T00:56:52ZNeurologic uses of botulinum neurotoxin type A1176-63281178-2021https://doaj.org/article/bd19972e45e94d59811dee16cc73c4b82007-01-01T00:00:00Zhttp://www.dovepress.com/neurologic-uses-of-botulinum-neurotoxin-type-a-a957https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021John P Ney, Kevin R JosephMadigan Army Medical Center, Neurology Service, Tacoma, WA, USAAbstract: This article reviews the current and most neurologic uses of botulinum neurotoxin type A (BoNT-A), beginning with relevant historical data, neurochemical mechanism at the neuromuscular junction. Current commercial preparations of BoNT-A are reviewed, as are immunologic issues relating to secondary failure of BoNT-A therapy. Clinical uses are summarized with an emphasis on controlled clinical trials (as appropriate), including facial movement disorders, focal neck and limb dystonias, spasticity, hypersecretory syndromes, and pain.Keywords: botulinum neurotoxins, BOTOX®, Dysport®, chemodenervation John P NeyKevin R JosephDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2007, Iss Issue 6, Pp 785-798 (2007)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
John P Ney
Kevin R Joseph
Neurologic uses of botulinum neurotoxin type A
description John P Ney, Kevin R JosephMadigan Army Medical Center, Neurology Service, Tacoma, WA, USAAbstract: This article reviews the current and most neurologic uses of botulinum neurotoxin type A (BoNT-A), beginning with relevant historical data, neurochemical mechanism at the neuromuscular junction. Current commercial preparations of BoNT-A are reviewed, as are immunologic issues relating to secondary failure of BoNT-A therapy. Clinical uses are summarized with an emphasis on controlled clinical trials (as appropriate), including facial movement disorders, focal neck and limb dystonias, spasticity, hypersecretory syndromes, and pain.Keywords: botulinum neurotoxins, BOTOX®, Dysport®, chemodenervation
format article
author John P Ney
Kevin R Joseph
author_facet John P Ney
Kevin R Joseph
author_sort John P Ney
title Neurologic uses of botulinum neurotoxin type A
title_short Neurologic uses of botulinum neurotoxin type A
title_full Neurologic uses of botulinum neurotoxin type A
title_fullStr Neurologic uses of botulinum neurotoxin type A
title_full_unstemmed Neurologic uses of botulinum neurotoxin type A
title_sort neurologic uses of botulinum neurotoxin type a
publisher Dove Medical Press
publishDate 2007
url https://doaj.org/article/bd19972e45e94d59811dee16cc73c4b8
work_keys_str_mv AT johnpney neurologicusesofbotulinumneurotoxintypea
AT kevinrjoseph neurologicusesofbotulinumneurotoxintypea
_version_ 1718403406194802688